Results 221 to 230 of about 27,026 (263)

A cytokine receptor-targeting chimera toolbox for expanding extracellular targeted protein degradation. [PDF]

Proc Natl Acad Sci U S A
Kumru K, Yao Z, Holmes BB, Zhao F, Zhang Y, Ferrara E, Peters-Clarke TM, Leung KK, Wells JA.   +8 more
europepmc   +1 more source

Progress in structure-based drug development targeting chemokine receptors. [PDF]

Front Pharmacol
Wang J, Qu C, Xiao P, Liu S, Sun JP, Ping YQ.   +5 more
europepmc   +1 more source

A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma. [PDF]

Int J Mol Sci
Gyau BB, Man TK.
europepmc   +1 more source

Managing Symptoms in Adolescent-Onset Schizophrenia: A Narrative Review of Therapeutic Interventions. [PDF]

Healthcare (Basel)
Abedi K.
europepmc   +1 more source

Decoy Receptors in Autoimmunity: Molecular Guardians and Pathogenic Players in Immune Dysregulation. [PDF]

Mediators Inflamm
Farahani H, Kokhaei P, Ganji A, Mosayebi G, Ghazavi A.   +4 more
europepmc   +1 more source

Multiscale Computational Dissection of CCRL2-Mediated Chemerin Presentation. [PDF]

J Chem Inf Model
Migliorini A, Di Cristofano S, Dishnica K, Marchetto A, Ribeiro RP, Laffranchi M, Cerioni E, Quilli F, Bonanni E, Giorgetti A, Rossetti G, Sozzani S, Borsello T, Raimondo D.   +13 more
europepmc   +1 more source

Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3. [PDF]

ACS Omega
Bérenger S, Adamska JM, Deflorian F, de Graaf C, Palmer CB, Szpakowska M, Chevigné A, de Esch IJP, Zarzycka B, Vischer HF, Wijtmans M, Leurs R.   +11 more
europepmc   +1 more source

CXC Chemokine-Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response. [PDF]

Adv Sci (Weinh)
Chen H, Huang Y, Wu J, Yi Z, Li Y, Yang Z, Zhang F, Li C.   +7 more
europepmc   +1 more source

Dendritic Cell Migration: An Essential Step in Initiating Adaptive Immunity Across Tissues. [PDF]

Immunol Rev
Olson EC, Williams A, Eisenbarth SC.
europepmc   +1 more source

CXCL1 in triple‑negative breast cancer: Mechanisms, challenges, and therapeutic opportunities (Review). [PDF]

Oncol Rep
Al Sayegh H, Assi Z, Kanaan A, El Sibai M.   +3 more
europepmc   +1 more source